L. Parker

Study on Adoptive Immunotherapy Using Gene-Modified TCells for Ovarian Cancer

S. Rosenberg, P. Hwu, S. Canevari, 2006 .

Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer.

S. Rosenberg, P. Hwu, M. Dudley, 2000, Human gene therapy.

Large-Scale Depletion of CD25+ Regulatory T Cells from Patient Leukapheresis Samples

S. Rosenberg, D. Powell, L. Parker, 2005, Journal of immunotherapy.

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

S. Rosenberg, J. Yannelli, K. Hines, 1996 .

Melanoma Tumor‐Infiltrating Lymphocytes Derived from Four Distinct Anatomic Sites Obtained from a Single Patient: Comparison of Functional Reactivity and Melanoma Antigen Recognition

M. Nishimura, J. Yang, P. Robbins, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience.

S. Rosenberg, J. Yannelli, K. Hines, 1996, International journal of cancer.

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

S. Rosenberg, C. Klebanoff, J. Yang, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Gang Wang, Steven A. Rosenberg, Zelig Eshhar, 2006, Clinical Cancer Research.

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy

S. Rosenberg, Yong-Chen Lu, P. Robbins, 2016, Journal of immunotherapy.

T Cell‐Receptor V Gene Use by CD4+ Melanoma‐Reactive Clonal and Oligoclonal T‐Cell Lines

S. Rosenberg, M. Nishimura, A. Mixon, 1998, Journal of immunotherapy.

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an In vitro melanoma model

F. Marincola, S. Ferrone, A. Mixon, 1999, International journal of cancer.

A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers

S. Rosenberg, C. Klebanoff, J. Yang, 2015, Journal of Immunotherapy for Cancer.